Biologics and Biosimilars
Pages: 528
Publisher: CRC Press
Year of Publication: 2024
Author(s) : Xiaodong Feng, Hong-Guang Xie, Ashim Malhotra, Catherine F. Yang
Book Description:
Biologics and Biosimilars: Drug Discovery and Clinical Applications is a systematic integration and evaluation of all aspects of biologics and biosimilars, encompassing research and development, clinical use, global regulation, and more. Biosimilars are biological therapeutic agents designed to imitate a reference biologic with high similarities in structure, efficacy, and safety, but also with potential clinical effective and cost-efficient options for the manufacturers, payers, clinicians, and patients. Most of the top-selling prescription drugs in the current market are biologics, which have revolutionized the treatment strategies and modalities for life-threatening and/or rare diseases.
This book outlines the key processes and challenges in drug development, regulations, and clinical applications of biologics, biosimilars, and even interchangeable biosimilars. Global experts in the field discuss essential categories and prototype drugs of biologics and biosimilars in clinical practice such as allergenics, blood and blood components, cell treatment, gene therapy, recombinant therapeutic proteins or peptides, tissues, and vaccines.
https://www.routledge.com/Biologics-and-Biosimilars-Drug-Discovery-and-Clinical-Applications/Feng-Xie-Malhotra-Yang/p/book/9781032262024
